Crilvastatin, a new 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, inhibits cholesterol absorption in genetically hypercholesterolemic rats.

MLA

Hajri, T., et al. “Crilvastatin, a New 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitor, Inhibits Cholesterol Absorption in Genetically Hypercholesterolemic Rats.” European Journal of Pharmacology, vol. 286, no. 2, Nov. 1995, pp. 131–36. EBSCOhost, https://doi.org/10.1016/0014-2999(95)00437-p.

APA

Hajri, T., Férézou, J., Laruelle, C., & Lutton, C. (1995). Crilvastatin, a new 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, inhibits cholesterol absorption in genetically hypercholesterolemic rats. European Journal of Pharmacology, 286(2), 131–136. https://doi.org/10.1016/0014-2999(95)00437-p

Chicago

Hajri, T, J Férézou, C Laruelle, and C Lutton. 1995. “Crilvastatin, a New 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitor, Inhibits Cholesterol Absorption in Genetically Hypercholesterolemic Rats.” European Journal of Pharmacology 286 (2): 131–36. doi:10.1016/0014-2999(95)00437-p.